Symbol="ASLN"
AssetType="Common Stock"
Name="Aslan Pharmaceuticals Ltd ADR"
Description="ASLAN Pharmaceuticals Limited, a biopharmaceutical company focused on clinical phase immunology, is dedicated to developing various treatments to transform the lives of patients. The company is headquartered in Singapore."
CIK="1722926"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="83 CLEMENCEAU AVENUE, #12-03 UE SQUARE, SINGAPORE, SG"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="35800400"
EBITDA="-44098624"
PERatio="None"
PEGRatio="None"
BookValue="0.339"
DividendPerShare="0"
DividendYield="0"
EPS="-3.76"
RevenuePerShareTTM="0.804"
ProfitMargin="0"
OperatingMarginTTM="-3.68"
ReturnOnAssetsTTM="-0.406"
ReturnOnEquityTTM="-2.377"
RevenueTTM="12000000"
GrossProfitTTM="79821000"
DilutedEPSTTM="-3.76"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="15.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="19.05"
PriceToBookRatio="1.584"
EVToRevenue="16.94"
EVToEBITDA="-0.062"
Beta="1.748"
num_52WeekHigh="4.769"
num_52WeekLow="1.702"
num_50DayMovingAverage="3.123"
num_200DayMovingAverage="3.171"
SharesOutstanding="16347200"
DividendDate="None"
ExDividendDate="None"
symbol="ASLN"
open="2.19"
high="2.19"
low="2.11"
price="2.15"
volume="6721.00"
latest_trading_day="2023-08-14"
previous_close="2.17"
change="-0.02"
change_percent="-0.9217%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="50"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="108915"
Change_recent_avg="0.01"
Delta_recent_avg="0.25"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-0.38"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="501"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0104.jpeg"
image_negative_thumbnail_id_2="500"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_neutral_thumbnail_id_1="574"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_neutral_thumbnail_id_2="538"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_positive_thumbnail_id_1="603"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0105.jpeg"
image_positive_thumbnail_id_2="632"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0076.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
